...
首页> 外文期刊>The Internet Journal of Urology >Upgrading of Standard and Transperineal Transrectal Ultrasound Guided Prostate Biopsies on Subsequent Radical Prostatectomy: A Population Based Study
【24h】

Upgrading of Standard and Transperineal Transrectal Ultrasound Guided Prostate Biopsies on Subsequent Radical Prostatectomy: A Population Based Study

机译:后续根治性前列腺切除术的标准和经会阴经直肠超声引导的前列腺穿刺活检的升级:基于人群的研究

获取原文
           

摘要

Gleason grade on prostate biopsy is a major component on which treatment decisions for prostate cancer are based. However a significant percentage, approximately 30% of patients with Gleason 6 disease who subsequently undergo radical prostatectomy are upgraded to Gleason 7 or higher.[1]Correct grading of prostate cancer in the Gleason 6 population when compared to radical prostatectomy histology occurs in approximately 50-60% of cases.[3]Grading inaccuracy on prostate biopsy is therefore of significant concern in patients who receive radiotherapy or active surveillance, as the true grade of their prostate cancer may never be determined and had they been upgraded they may not have opted for non-extirpative treatment.This study therefore, utilises the population based SA-PCCOC (South Australian Prostate Cancer Outcome Collaborative) database to assess upgrading in Gleason 7 prostate cancer, as this group of patients are candidates for both surgical, radiotherapy and surveillance treatment options. (AUA guidelines for management of localised prostate cancer 2007, updated 2009)A further analysis is performed to assess the upgrading rate for transperineal prostate biopsy (TP) as this technique has been suggested to be a means to improve grading accuracy in prostate cancer .[4] BACKGROUND Gleason grade on prostate biopsy is a major component on which treatment decisions for prostate cancer are based. However a significant percentage, approximately 30% of patients with Gleason 6 disease who subsequently undergo radical prostatectomy are upgraded to Gleason 7 or higher.[1]Correct grading of prostate cancer in the Gleason 6 population when compared to radical prostatectomy histology occurs in approximately 50-60% of cases.[3]Grading inaccuracy on prostate biopsy is therefore of significant concern in patients who receive radiotherapy or active surveillance, as the true grade of their prostate cancer may never be determined and had they been upgraded they may not have opted for non-extirpative treatment.This study therefore, utilises the population based SA-PCCOC (South Australian Prostate Cancer Outcome Collaborative) database to assess upgrading in Gleason 7 prostate cancer, as this group of patients are candidates for both surgical, radiotherapy and surveillance treatment options. (AUA guidelines for management of localised prostate cancer 2007, updated 2009)A further analysis is performed to assess the upgrading rate for transperineal prostate biopsy (TP) as this technique has been suggested to be a means to improve grading accuracy in prostate cancer .[4] METHODS The SA-PCCOC database was initiated in 1996 and is the largest population based, prospective prostate cancer database in the Southern Hemisphere. It contains more than 7500 patients and captures approximately 50% of all new prostate cancer diagnosis in South Australia, from both the private and public sectors. Current accrual is approximately 1000 new patients every year.An initial audit was performed in 2011 to assess the rate of upgrading in patients with Gleason 7 prostate cancer on standard TRUS biopsy (either 3+4 or 4+3), who subsequently had a radical prostatectomy.A subsequent audit was performed in 2012 to assess the rate of upgrading in patients who underwent a TP biopsy (any Gleason grade) and subsequently had a radical prostatectomy.Explanatory variables assessed for the two populations included: patient demographics, PSA, TRUS biopsy grade, total cores, total positive cores, histology and duration to radical prostatectomy.A separate analysis was performed in the standard TRUS biopsy population to assess upgrading in ‘low volume’ Gleason 4 disease.This was defined as patients who had only 1 core positive for Gleason 4 disease, or 2 cores positive for Gleason 4 disease if more than 10 cores were taken.The primary outcome variable for both populations was upgrading which was defined as:- Increase in Gleason grade from 3+4 to 4+3 or higher- Any increase in total Gl
机译:前列腺活检的格里森评分是前列腺癌治疗决策的主要依据。然而,随后进行根治性前列腺切除术的Gleason 6病患者中,有大约30%的患者升级为Gleason 7或更高。[1]与根治性前列腺切除术的组织学相比,格里森6人群中前列腺癌的正确分级-60%的病例。[3]因此,在接受放射治疗或积极监测的患者中,前列腺活检的分级不准确是一个重大问题,因为他们的前列腺癌的真实分级可能永远无法确定,如果升级,他们可能没有选择因此,本研究利用基于人群的SA-PCCOC(南澳大利亚前列腺癌结果协作数据库)评估了格里森7型前列腺癌的升级情况,因为该组患者同时适合手术,放疗和监测治疗选项。 (AUA局限性前列腺癌管理指南,2007年更新,2009年)进行了进一步的分析,以评估经会阴前列腺活检(TP)的升级率,因为该技术被认为是提高前列腺癌分级准确性的一种手段。[ [4]背景前列腺活检的格里森评分是前列腺癌治疗决策所依据的主要组成部分。然而,随后进行根治性前列腺切除术的Gleason 6病患者中,有大约30%的患者升级为Gleason 7或更高。[1]与根治性前列腺切除术的组织学相比,格里森6人群中前列腺癌的正确分级-60%的病例。[3]因此,在接受放射治疗或积极监测的患者中,前列腺活检的分级不准确是一个重大问题,因为他们的前列腺癌的真实分级可能永远无法确定,如果升级,他们可能没有选择因此,本研究利用基于人群的SA-PCCOC(南澳大利亚前列腺癌结果协作数据库)评估了格里森7型前列腺癌的升级情况,因为该组患者同时适合手术,放疗和监测治疗选项。 (AUA局限性前列腺癌管理指南,2007年更新,2009年)进行了进一步的分析,以评估经会阴前列腺活检(TP)的升级率,因为该技术被认为是提高前列腺癌分级准确性的一种手段。[ 4]方法SA-PCCOC数据库始于1996年,是南半球最大的基于人群的前瞻性前列腺癌数据库。它包含了7500多名患者,并捕获了南澳大利亚州来自私人和公共部门的所有新的前列腺癌诊断的大约50%。目前每年大约有1000名新患者入选.2011年进行了初次审核,以评估接受标准TRUS活检(3 + 4或4 + 3)的格里森7前列腺癌患者的升级率,随后进行了彻底的前列腺切除术.2012年进行了后续审核,以评估接受TP活检(任何Gleason分级)并随后行根治性前列腺切除术的患者的升级率。对这两个人群评估的解释性变量包括:患者人口统计学,PSA,TRUS活检等级,总核心,总阳性核心,组织学和根治性前列腺切除术的持续时间。在标准TRUS活检人群中进行了单独的分析,以评估“小容量”格里森4病的升级。对于格里森4病,如果采用10个以上的核心,则格里森4疾病为2个核心阳性。两个人群的主要结局变量是升级,其定义为如:-格里森等级从3 + 4增加到4 + 3或更高-总Gl的任何增加

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号